Nurix Therapeutics ups ATM equity offering capacity to $413.65M

Nurix Therapeutics, Inc.

Amendment No. 3 to Equity Distribution Agreement with Piper Sandler dated March 6, 2026.
Maximum aggregate gross offering price of common stock increased from $300M to $413.65M.
Shares offered at-the-market from time to time; prospectus supplement filed same day.
Proceeds not specified; prior ATM sales included in the increased limit.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.